Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

Compared with other epithelial ovarian carcinoma subtypes, ovarian clear cell carcinoma (OCCC) has been recognized to show chemoresistance. Therefore, new treatment modalities are required for patients with OCCC that is refractory to chemotherapy. The carcinoembryonic antigen glypican-3 (GPC3) is ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shiro, Sakata, Jun, Utsumi, Fumi, Sekiya, Ryuichiro, Kajiyama, Hiroaki, Shibata, Kiyosumi, Kikkawa, Fumitaka, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139642/
https://www.ncbi.nlm.nih.gov/pubmed/27999758
http://dx.doi.org/10.1080/2162402X.2016.1238542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139642/
https://www.ncbi.nlm.nih.gov/pubmed/27999758
http://dx.doi.org/10.1080/2162402X.2016.1238542

Ejemplares similares